Clinical Trial Results: Jardiance® Post Marketing Surveillance (PMS) in Korean Patients With Chronic Heart Failure

View source ↗

Summary

Clinical trial results from post-marketing surveillance of Jardiance in Korean patients with chronic heart failure have been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Jardiance (empagliflozin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Heart Failure | Status: COMPLETED | Results posted: 2026-08-10